Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-10-01
1992-03-03
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 48, 5142245, A61K 3154, C07D51300
Patent
active
050933329
ABSTRACT:
Thieno[2,3-b][1,4]thiazine-6-sulfonamides having the structural formula: ##STR1## wherein Z, R.sup.1, R.sup.2, and n are as hereinafter defined, are carbonic anhydrase inhibitors useful in the topical treatment of elevated intraocular pressure and glaucoma.
REFERENCES:
patent: 4677115 (1987-06-01), Baldwin et al.
patent: 4797413 (1989-01-01), Baldwin et al.
patent: 4820848 (1989-04-01), Poticello et al.
patent: 4824968 (1989-04-01), Ponticello et al.
patent: 4863922 (1989-09-01), Baldwin et al.
Paulmier, C., Tetrahedron Lett., 1978, 21, 1797-1800 (I) French Language.
Paulmier, C., Bull. Soc. Chim. Fr., 1980, II, 151-156 (II) French Language.
Hunt Cecilia A.
Shepard Kenneth L.
DiPrima Joseph F.
Grumbling Matthew V.
Merck & Co. , Inc.
Nicholson William H.
Shah Mukund J.
LandOfFree
Substituted thieno(2,3-B)(1,4)thiazine-6-sulfonamides as antigla does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted thieno(2,3-B)(1,4)thiazine-6-sulfonamides as antigla, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted thieno(2,3-B)(1,4)thiazine-6-sulfonamides as antigla will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-272310